LOUISVILLE, Ky. — Researcher at the University of Louisville say they have developed a technology that might be able to block the novel coronavirus from infecting human cells.
According to a recent article published by the university, the technology is based on a piece of synthetic DNA called an “aptamer,” which targets and binds with a human protein called nucleolin. Researchers say early tests show the aptamer may stop viruses, including novel coronavirus, from “hijacking” nucleolin to replicate inside the body.
UofL is seeking to fast-track development, including applying to the Food and Drug Administration for approval to start treating patients seriously affected by COVID-19.
Credit for the discovery of the aptamer goes to UofL’s Paula Bates, John Trent and Don Miller.The three researchers have applied it in a variety of ways, most notably as a potential therapeutic drug against multiple types of cancer, according to the article.
You can read the full article here.
UofL say they are providing financial support for COVID-19 research, but additional funds are needed to continue the work over time. Donations specifically for the research can be made online here.
Other stories on WHAS11 News:
Want to know the top stories of the day? Sign-up for WHAS11’s daily newsletter here.